FCCC LOGO Faculty Publications
Hoppe RT , Advani RH , Ai WZ , Ambinder RF , Aoun P , Armand P , Bello CM , Benitez CM , Bierman PJ , Chen R , Dabaja B , Dean R , Forero A , Gordon LI , Hernandez-Ilizaliturri FJ , Hochberg EP , Huang J , Johnston PB , Kaminski MS , Kenkre VP , Khan N , Maddocks K , Maloney DG , Metzger M , Moore JO , Morgan D , Moskowitz CH , Mulroney C , Rabinovitch R , Seropian S , Tao R , Winter JN , Yahalom J , Burns JL , Ogba N
NCCN Guidelines Insights: Hodgkin Lymphoma, Version 1.2018
J Natl Compr Canc Netw. 2018 Mar;16(3) :245-254
PMID: 29523663   
Back to previous list
Abstract
The NCCN Clinical Practice Guidelines in Oncology for Hodgkin Lymphoma (HL) provide recommendations for the management of adult patients with HL. The NCCN Guidelines Panel meets at least annually to review comments from reviewers within the NCCN Member Institutions, examine relevant data, and reevaluate and update the recommendations. These NCCN Guidelines Insights summarize recent updates centered on treatment considerations for relapsed/refractory classic HL.
Notes
1540-1413 Hoppe, Richard T Advani, Ranjana H Ai, Weiyun Z Ambinder, Richard F Aoun, Patricia Armand, Philippe Bello, Celeste M Benitez, Cecil M Bierman, Philip J Chen, Robert Dabaja, Bouthaina Dean, Robert Forero, Andres Gordon, Leo I Hernandez-Ilizaliturri, Francisco J Hochberg, Ephraim P Huang, Jiayi Johnston, Patrick B Kaminski, Mark S Kenkre, Vaishalee P Khan, Nadia Maddocks, Kami Maloney, David G Metzger, Monika Moore, Joseph O Morgan, David Moskowitz, Craig H Mulroney, Carolyn Rabinovitch, Rachel Seropian, Stuart Tao, Randa Winter, Jane N Yahalom, Joachim Burns, Jennifer L Ogba, Ndiya Journal Article United States J Natl Compr Canc Netw. 2018 Mar;16(3):245-254. doi: 10.6004/jnccn.2018.0013.